The Saudi Dental Journal · Nov 16, 2026
Opportunistic screening for diabetes and hypertension in dental settings and its implications for Saudi Arabia’s health sector transformation: a narrative review
By Alamoudi W
Purpose: Saudi Arabia carries one of the highest global burdens of undiagnosed diabetes mellitus and hypertension, while its dental sector risks marginalisation from the public health agenda under Vision 2030’s Health Sector Transformation Program (HSTP). This narrative review aimed to synthesise international evidence on the feasibility, clinical validity, and health system value of opportunistic screening for diabetes mellitus and hypertension in dental settings, and to evaluate these findings against the structural components of the HSTP. Methods: A narrative review was conducted using the Scale for the Assessment of Narrative Reviews (SANRA) as a quality framework. A structured literature search was performed across PubMed, Scopus, Web of Science, and Google Scholar (January 2000 to July 2026), and records were screened against predefined eligibility criteria. Peer-reviewed studies, systematic reviews, and institutional policy documents addressing opportunistic dental screening for diabetes mellitus and hypertension, Saudi epidemiology, and the HSTP architecture were included. Of 953 records identified, 172 studies met the eligibility criteria and 31 were selected for the synthesis using predefined rules. Results: Global literature consistently demonstrates detection of undiagnosed or poorly controlled diabetes mellitus and hypertension in dental clinic populations, with dental risk scores and point-of-care glycated haemoglobin testing showing moderate accuracy and high patient acceptability, although single chair-side blood pressure readings require confirmation. Referral pathway integrity is the critical implementation determinant. Saudi Arabia’s epidemiological profile, dental workforce density, and emerging digital health infrastructure, including the Sehhaty platform and Health Cluster architecture, create favourable conditions for formalising this screening role, although no Saudi study has yet evaluated referral outcomes. Conclusion: Integrating opportunistic non-communicable disease screening into dental workflows within Saudi Health Clusters is supported by consistent observational evidence and aligned with Vision 2030’s population health targets, but should be piloted before wider adoption. The Centre for National Health Insurance could incorporate dental screening metrics into its value-based reimbursement framework, and oral health should be embedded within the national primary care pathway. Targeted recommendations are proposed for the Health Holding Company, the Centre for National Health Insurance and the Saudi Commission for Health Specialties.
doi.org/10.1007/s44445-026-00269-2Open accessPubMed 43037907Biomarkers